Remdesivir may help treat Covid-19 but the predictable media hype misrepresents the science. The data has not been published nor peer reviewed. There is a study in the Lancet that does not demonstrate efficacy hence the need for further investigation to determine if this truly is a treatment option.

Medical Mythbusting Commentary for April 30, 2020

Remdesivir: Drug has ‘clear-cut’ power to fight coronavirus

The COVID-19 research news rollercoaster is running again: STAT News + Gilead’s remdesivir

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial